FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/04/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
CORE BIOGENESIS
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals, namely, for use in industry and science; proteins and other molecules for use in medical research; proteins as industrial chemicals for manufacturing or as ingredients in cell culture media and diagnostic preparations; proteins and other biomolecules of pharmaceuticals (biopharmaceuticals); enzymes and other molecules for industrial and scientific use; biological preparations for use in industry and science; cell growth media for growing cells and for use in scientific, biological and biotechnological research; biological preparations, namely, fats and lipids, proteins, peptides, living cells, living tissue, laboratory-grown living cells, laboratory-grown living tissue for use in industry and science
Classe 5
Pharmaceutical; stem cells for medical, clinical, pharmaceutical and veterinary use; cell growth media for growing cells for medical, clinical, pharmaceutical and veterinary use; chemical preparations for medical, clinical, pharmaceutical and veterinary use; biological preparations for medical, clinical, pharmaceutical and veterinary use; bacterial preparations for medical, clinical, pharmaceutical and veterinary use; microbiological culture media for medical, clinical, pharmaceutical and veterinary use; enzyme preparations for medical, clinical, pharmaceutical and veterinary use; diagnostic preparations for medical, clinical, pharmaceutical and veterinary use; biological products in the nature of cell preparations for medical, clinical, pharmaceutical and veterinary use
Classe 10
Apparatus for the regeneration of stem cells for medical use
Classe 42
Chemical research; scientific research; biological research; chemical analysis; molecular research; genetic research; cell research
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
16/04/2026
FINAL DISPOSITION NOTICE SENT TO IB
27/03/2026
FINAL DISPOSITION PROCESSED
27/03/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/12/2025
REGISTERED-PRINCIPAL REGISTER
16/09/2025
TTAB RELEASE CASE TO TRADEMARKS
23/08/2025
OPPOSITION TERMINATED NO. 999999
23/08/2025
OPPOSITION SUSTAINED NO. 999999
23/08/2025
REFUSAL PROCESSED BY IB
31/05/2025
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
15/05/2025
OPPOSITION INSTITUTED NO. 999999
15/05/2025
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
13/05/2025
OPPOSITION NOTICE (IB REFUSAL) CREATED
13/05/2025
EXTENSION OF TIME TO OPPOSE RECEIVED
22/01/2025
PUBLISHED FOR OPPOSITION
14/01/2025
NOTICE OF PUBLICATION
08/01/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
17/12/2024
NEW REPRESENTATIVE AT IB RECEIVED
06/07/2024
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
30/06/2024
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
20/06/2024
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/06/2024
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/06/2024
NEW REPRESENTATIVE AT IB RECEIVED
20/05/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/08/2023
NON-FINAL ACTION WRITTEN
23/08/2023
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
22/08/2023
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/07/2023
NON-FINAL ACTION WRITTEN
28/07/2023
ASSIGNED TO EXAMINER
25/07/2023
NEW REPRESENTATIVE AT IB RECEIVED
11/03/2023
APPLICATION FILING RECEIPT MAILED
31/12/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/12/2022
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/12/2022
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.